2017
Different Chronotherapy Protocols Applied to Blood Pressure
CORNELISSEN, G., Y. WATANABE, Jarmila SIEGELOVÁ, Jiří DUŠEK, Alena HAVELKOVÁ et. al.Základní údaje
Originální název
Different Chronotherapy Protocols Applied to Blood Pressure
Autoři
CORNELISSEN, G., Y. WATANABE, Jarmila SIEGELOVÁ, Jiří DUŠEK, Alena HAVELKOVÁ, Leona DUNKLEROVÁ, C. TURNER, L. BEATY a K. OTSUKA
Vydání
Brno, Noninvasive methods in cardiology 2017, od s. 69-82, 2017
Nakladatel
Masarykova univerzita
Další údaje
Jazyk
angličtina
Typ výsledku
Stať ve sborníku
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Organizační jednotka
Lékařská fakulta
ISBN
978-80-210-8794-1
Změněno: 26. 3. 2021 14:51, Mgr. Tereza Miškechová
Anotace
V originále
Blood pressure serves both as a marker variable and as a gauge of the response to timed treatment (chronotherapy). The relative merits of several transverse and longitudinal chronotherapy designs are reviewed herein, from small studies on groups and N-of-6 pilot studies to larger clinical trials. Some chronotherapy designs are aimed at optimal results for the average patient in a given target population, while others aim at personalized chronotherapy, where each patient in the study is considered as an N-of-1 pilot. All chronotherapy trials considered herein relied on around-the-clock blood pressure measurements obtained automatically to determine optimal treatment times. Because anti-hypertensive medications can affect the circadian amplitude in addition to the rhythm-adjusted average (MESOR), treatment effects should be assessed on all characteristics of the circadian blood pressure rhythm. Because abnormal blood pressure and heart rate variability also relates to cardiovascular disease risk, anti-hypertensive treatment should target not only the lowering of blood pressure, but also the restoration of an acceptable circadian variation in blood pressure. Methods to analyze individual blood pressure records makes it now feasible to determine personalized optimal treatment times. Outcome studies remain to be performed to assess the gain to be obtained from personalized chronotherapy in terms of an actual decrease in adverse cardiovascular events.